Iodometomidate (I-123)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Iodometomidate (I-123), covering 2025-06-10 to 2025-06-10. Get the full timeline:
Most recent: Clinical Trial Update: Combined FDG-PET and 123I-Iodometomidate Imaging for Adrenal Neoplasia [Phase 3]